Accolade Inc. (NASDAQ: ACCD) stock closed at 17.98 per share at the end of the most recent trading day (a -1.86% change compared to the prior day closing price) with a volume of 972.61K shares and market capitalization of 717.93M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 1230 people. Accolade Inc. CEO is Rajeev Singh.

The one-year performance of Accolade Inc. stock is %, while year-to-date (YTD) performance is -43.77%. ACCD stock has a five-year performance of %. Its 52-week range is between 6.83 and 17.005, which gives ACCD stock a 52-week price range ratio of 28.70%

Accolade Inc. currently has a PE ratio of -1.30, a price-to-book (PB) ratio of 1.06, a price-to-sale (PS) ratio of 2.09, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -39.92%, a ROC of -43.33% and a ROE of -71.05%. The company’s profit margin is -30.72%, its EBITDA margin is -99.70%, and its revenue ttm is $266.93 Million , which makes it $3.71 revenue per share.

Of the last four earnings reports from Accolade Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.56 for the next earnings report. Accolade Inc.’s next earnings report date is 04th Oct 2023.

The consensus rating of Wall Street analysts for Accolade Inc. is Moderate Buy (1.57), with a target price of $13.63, which is +39.79% compared to the current price. The earnings rating for Accolade Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Accolade Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Accolade Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.18, ATR14 : 1.29, CCI20 : 158.09, Chaikin Money Flow : 0.02, MACD : 0.00, Money Flow Index : 63.98, ROC : 39.16, RSI : 0.00, STOCH (14,3) : 86.83, STOCH RSI : 0.00, UO : 62.70, Williams %R : -13.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Accolade Inc. in the last 12-months were: Barnes Stephen (Option Excercise at a value of $0), Barnes Stephen (Sold 6 824 shares of value $84 909 ), Barnes Stephen H. (Sold 2 576 shares of value $35 575 ), Brodsky Jeffrey (Option Excercise at a value of $0), Cavanaugh Robert (Option Excercise at a value of $0), Cavanaugh Robert (Sold 7 350 shares of value $91 111 ), Cavanaugh Robert N (Sold 2 511 shares of value $34 677 ), Colin McHugh (Sold 0 shares of value $0 ), Colin McHugh (Sold 728 shares of value $10 161 ), Eskew Richard (Sold 489 shares of value $7 024 ), Hilton Michael (Option Excercise at a value of $0), Hilton Michael (Sold 3 326 shares of value $37 419 ), Jeffrey S. Brodsky (Option Excercise at a value of $0), McHugh Colin (Sold 370 shares of value $5 315 ), Michael W. Hilton (Option Excercise at a value of $0), Michael W. Hilton (Sold 890 shares of value $8 949 ), Nabel Elizabeth (Sold 0 shares of value $0 ), Peter S. Klein (Option Excercise at a value of $0), Rajeev Singh (Option Excercise at a value of $0), Rajeev Singh (Sold 1 171 shares of value $12 216 ), Richard Eskew (Option Excercise at a value of $5 065), Richard Eskew (Sold 4 102 shares of value $51 096 ), Robert Cavanaugh (Option Excercise at a value of $0), Robert Cavanaugh (Sold 814 shares of value $8 628 ), Singh Rajeev (Option Excercise at a value of $1 829 096), Singh Rajeev (Sold 18 039 shares of value $227 458 ), Stephen Barnes (Option Excercise at a value of $0), Stephen Barnes (Sold 631 shares of value $6 699 ), Thomas J. Neff (Option Excercise at a value of $0)